Yajing Lyu

7PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 06, 2026
Targeting conserved domains of hypoxia-inducible factors for cancer therapy.

Shaima Salman, Tina Y Huang, Yousang Hwang

|Dec 12, 2025
HIF-1-mediated ISG20 expression promotes breast cancer stemness and immune evasion.

Yongkang Yang, Qiaozhu Zuo, Vijay Ramu

|Aug 28, 2024
Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy.

Walter Jackson Iii, Yongkang Yang, Shaima Salman

|Dec 09, 2022
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.

Yongkang Yang, Chelsey Chen, Qiaozhu Zuo

|Jan 15, 2022
HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia.

Yongkang Yang, Haiquan Lu, Chelsey Chen

|Aug 28, 2021
Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization.

Yufeng Wang, Yajing Lyu, Kangsheng Tu

Pageof 2

Frequent Collaborators

6 joint publications

Gregg L Semenza

4 joint publications

Chelsey Chen

4 joint publications

Shaima Salman

4 joint publications

Yongkang Yang